Covid Vaccine Singapore Pfizer. When it comes to the immune memory, it is hard to say at this point, as the. As authorities in the us and.
But the news from pfizer and biontech could be heartening to other vaccine developers as well. Pfizer’s chief executive has said that it could have 30 to 40 million doses of the vaccine before the end of the year, enough for 15 to 20 million people to get an initial shot and a booster. Pfizer and biontech reported final trial results on nov.
Nyi nyi thet | december 08, 2020, 04:09 pm.
Pfizer and biontech reported final trial results on nov. Pfizer’s chief executive has said that it could have 30 to 40 million doses of the vaccine before the end of the year, enough for 15 to 20 million people to get an initial shot and a booster. When it comes to the immune memory, it is hard to say at this point, as the. Previous work to develop a vaccine against the coronavirus diseases sars and mers established knowledge about the structure and function of coronaviruses, which accelerated development during early 2020 of varied technology platforms for a.